Mimedx (MDXG) Asset Utilization Ratio (2011 - 2026)
Mimedx's (MDXG) quarterly Asset Utilization Ratio came in at 1.2 in Q1 2026, down 9.34% year-on-year from 1.32 in Q1 2025, and down 5.51% quarter-over-quarter from 1.27 in Q4 2025.
Mimedx (MDXG) Asset Utilization Ratio (2011 - 2026) Analysis & Trends
Mimedx has disclosed Asset Utilization Ratio across 15 years of filings, most recently posting 1.2 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 1.2, down 9.34% year-over-year; the trailing twelve-month figure through Mar 2026 was 1.2 (down 9.34% YoY), and the FY2025 annual result was 1.38, down 0.5% from the prior year.
- Asset Utilization Ratio came in at 1.2 for Q1 2026 at Mimedx, down from 1.27 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 1.71 in Q2 2023 to a low of 1.2 in Q1 2026.
- The 5-year median for Asset Utilization Ratio is 1.43 (2022), against an average of 1.44.
- Across the five-year window, Asset Utilization Ratio grew 24.28% in 2023 and declined 14.5% in 2024, its largest moves.
- Mimedx's Asset Utilization Ratio stood at 1.56 in 2022, then fell by 3.48% to 1.5 in 2023, then declined by 8.52% to 1.37 in 2024, then fell by 7.91% to 1.27 in 2025, then decreased by 5.51% to 1.2 in 2026.
- The last three Asset Utilization Ratio figures came in at 1.2 (Q1 2026), 1.27 (Q4 2025), and 1.29 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Mimedx | 546.28 Mn | 386.51 Mn | 41.62 Mn | 1.20 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.20 |
| Dec 31, 2025 | 1.27 |
| Sep 30, 2025 | 1.29 |
| Jun 30, 2025 | 1.30 |
| Mar 31, 2025 | 1.32 |
| Dec 31, 2024 | 1.37 |
| Sep 30, 2024 | 1.45 |
| Jun 30, 2024 | 1.51 |
| Mar 31, 2024 | 1.45 |
| Dec 31, 2023 | 1.50 |
| Sep 30, 2023 | 1.69 |
| Jun 30, 2023 | 1.71 |
| Mar 31, 2023 | 1.65 |
| Dec 31, 2022 | 1.56 |
| Sep 30, 2022 | 1.43 |
| Jun 30, 2022 | 1.40 |
| Mar 31, 2022 | 1.33 |
| Dec 31, 2021 | 1.31 |
| Sep 30, 2021 | 1.41 |
| Jun 30, 2021 | 1.38 |